Topics

US regulators grant orphan drug status to AstraZeneca’s Imfinzi cancer drug

04:50 EDT 12 Jul 2019 | Proactive Investors

Imfinzi recently showed in a late-stage study that, when combined with chemotherapy, it had a “clinically meaningful” effect on overall survival

Original Article: US regulators grant orphan drug status to AstraZeneca’s Imfinzi cancer drug

NEXT ARTICLE

More From BioPortfolio on "US regulators grant orphan drug status to AstraZeneca’s Imfinzi cancer drug"

Quick Search